I had the same feeling about the oppies conversion. I don't think the current big holders want to do another capital rising and overdilute the shares anyway. And i still have the feeling that the share price is pushed up by some big guns.
Went down to 9.1 today and then pushed back to 9.5.
On the company itself, they ate a lot of money this quarter, probably to get the licence and do all the test for the graphene.
So nothing new this quarter except that the money spending went a bit wild.
It seems it was worth it.
I would watch closely the
-"Graphene product testing commenced with industrial parties"
-"Ongoing land access agreements to provide the future exploration path in the FGR priority areas " they are playing the long game, which is good.
-"Further drilling at the Aluketiya mining license which may provide further production potential." Sounds a bit doubtful. Production doesn't look imminent.
- Forums
- ASX - By Stock
- FGR
- Ann: Quarterly Activities Report-FGR.AX
Ann: Quarterly Activities Report-FGR.AX, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FGR (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $34.94M |
Open | High | Low | Value | Volume |
5.3¢ | 5.3¢ | 5.2¢ | $13.35K | 254.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 194671 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 176380 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 194671 | 0.051 |
5 | 612400 | 0.050 |
4 | 216450 | 0.048 |
1 | 76000 | 0.046 |
1 | 111111 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 176380 | 3 |
0.056 | 447410 | 4 |
0.057 | 50000 | 1 |
0.058 | 25000 | 1 |
0.059 | 75000 | 2 |
Last trade - 15.46pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FGR (ASX) Chart |